DK2296686T4 - Orodispersibel desmopressin til forlængelse af indledende søvnfase uforstyrret af nykturi - Google Patents
Orodispersibel desmopressin til forlængelse af indledende søvnfase uforstyrret af nykturi Download PDFInfo
- Publication number
- DK2296686T4 DK2296686T4 DK09751584.5T DK09751584T DK2296686T4 DK 2296686 T4 DK2296686 T4 DK 2296686T4 DK 09751584 T DK09751584 T DK 09751584T DK 2296686 T4 DK2296686 T4 DK 2296686T4
- Authority
- DK
- Denmark
- Prior art keywords
- desmopressin
- dose
- nocturnal
- paragraph
- nocturia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Claims (12)
1. Sammensætning omfattende desmopressin til anvendelse i behandling af en kvindelig patient med nykturi eller natlig polyuri ved reduktion af natligt urinvolumen hos den kvindelige patient med behov derfor, hvor sammensætningen omfatter en orodispersibel dosis af desmopressin på 25 pg til indgift før sengetid, hvor dosen er målt som den frie base af desmopressin.
2. Sammensætning til anvendelse ifølge krav 1 til reduktion af natligt urinvolumen hos en kvindelig patient over 50 år.
3. Sammensætning til anvendelse ifølge krav 1 til reduktion af natligt urinvolumen hos en kvindelig patient over 65 år, hvor sammensætningen omfatter en orodispersibel dosis af desmopressin på 25 pg sammensætning, hvor dosen er målt som den frie base af desmopressin.
4. Sammensætning til anvendelse ifølge krav 1, 2 eller 3, hvor dosen af fri desmo-pressinbase tilføres i form af acetatsaltet af desmopressin.
5. Sammensætning til anvendelse ifølge krav 1, 2 eller 3, hvor den orodispersible dosis af desmopressin er en doseringsform omfattende desmopressinacetat, gelatine, mannitol og citronsyre.
6. Sammensætning til anvendelse ifølge krav 1, hvor behandlingsperioden er 28 dage.
7. Sammensætning til anvendelse ifølge krav 1, hvor reduktionen varierer fra 143 ml til 358 ml.
8. Sammensætning til anvendelse ifølge krav 7, hvor reduktionen er fra 238 ml til 358 ml, hvor reduktionen for eksempel er 298 ml for 25 pg-dosen af desmopressin.
9. Sammensætning til anvendelse ifølge krav 2, hvor reduktionen varierer fra 120 ml til 460 ml.
10. Sammensætning til anvendelse ifølge krav 9, hvor reduktionen varierer fra 306 ml til 460 ml, hvor reduktionen for eksempel er 383 ml for 25 pg-dosen af desmopressin.
11. Sammensætning til anvendelse ifølge krav 3, hvor reduktionen varierer fra 306 ml til 460 ml, hvor reduktionen for eksempel varierer fra 345 til 421 ml, hvor reduktionen for eksempel er 383 ml.
12. Sammensætning til anvendelse ifølge krav 3, hvor patienten under søvn har en urinproduktionsrate som er større end patientens samlede gennemsnitlige daglige urinproduktionsrate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5512008P | 2008-05-21 | 2008-05-21 | |
PCT/US2009/044860 WO2009143356A1 (en) | 2008-05-21 | 2009-05-21 | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
Publications (2)
Publication Number | Publication Date |
---|---|
DK2296686T3 DK2296686T3 (da) | 2014-05-12 |
DK2296686T4 true DK2296686T4 (da) | 2018-01-02 |
Family
ID=41100519
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16165875.2T DK3085381T3 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forøgelse den initielle periode af søvn uforstyret af nyturi |
DK17171152.6T DK3225249T3 (da) | 2008-05-21 | 2009-05-21 | Orodispergerbar desmopressin til at øge indledende periode med søvn uforstyrret af nykturi |
DK09751584.5T DK2296686T4 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forlængelse af indledende søvnfase uforstyrret af nykturi |
DK13181216.6T DK2712622T3 (da) | 2008-05-21 | 2009-05-21 | Orodispergibel desmopressin til forlængelse af indledende søvnperiode, uforstyrret af nykturi. |
DK17171155T DK3225250T3 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16165875.2T DK3085381T3 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forøgelse den initielle periode af søvn uforstyret af nyturi |
DK17171152.6T DK3225249T3 (da) | 2008-05-21 | 2009-05-21 | Orodispergerbar desmopressin til at øge indledende periode med søvn uforstyrret af nykturi |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13181216.6T DK2712622T3 (da) | 2008-05-21 | 2009-05-21 | Orodispergibel desmopressin til forlængelse af indledende søvnperiode, uforstyrret af nykturi. |
DK17171155T DK3225250T3 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi |
Country Status (16)
Country | Link |
---|---|
US (2) | US9974826B2 (da) |
EP (5) | EP2296686B2 (da) |
JP (5) | JP5767103B2 (da) |
CA (1) | CA2724653A1 (da) |
DK (5) | DK3085381T3 (da) |
ES (5) | ES2462465T5 (da) |
HR (4) | HRP20161066T1 (da) |
HU (5) | HUE030409T2 (da) |
LT (5) | LT3225250T (da) |
LU (1) | LUC00015I2 (da) |
NO (3) | NO2296686T3 (da) |
PL (5) | PL3085381T3 (da) |
PT (5) | PT3085381T (da) |
SI (4) | SI3085381T1 (da) |
TR (2) | TR201819189T4 (da) |
WO (1) | WO2009143356A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US20100286045A1 (en) * | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
PT3085381T (pt) * | 2008-05-21 | 2018-05-18 | Ferring Bv | Desmopressina orodispersível para aumentar o período inicial de sono não perturbado pela noctúria |
WO2015063602A1 (en) * | 2013-10-29 | 2015-05-07 | Ferring B.V. | Desmopressin and blood glucose |
KR20210078500A (ko) * | 2018-10-17 | 2021-06-28 | 닛뽕 케미파 가부시키가이샤 | 야간 다뇨의 치료 또는 예방제 |
KR20230005819A (ko) * | 2020-04-14 | 2023-01-10 | 닛뽕 케미파 가부시키가이샤 | 수면의 질의 개선제 |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (147)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH495957A (de) | 1966-09-15 | 1970-09-15 | Ceskoslovenska Akademie Ved | Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids |
US4316893A (en) | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
US4405616A (en) | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
US4285858A (en) | 1979-10-30 | 1981-08-25 | Mt. Sinai School Of Medicine Of The City University Of N.Y. | Vasopressin analogs |
US4263283A (en) | 1980-05-16 | 1981-04-21 | Ferring Pharmaceuticals, Inc. | Method for prophylaxis and/or treatment of sickle cell disease |
GB2111423B (en) | 1981-12-02 | 1985-06-26 | Wyeth John & Brother Ltd | Making quick-dissolving pills |
ATE24964T1 (de) | 1981-12-11 | 1987-01-15 | Wyeth John & Brother Ltd | Verfahren zur herstellung von festen formgegenstaenden. |
US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
SE8306367L (sv) | 1983-11-18 | 1985-05-19 | Ferring Ab | Antidiuretiskt verkande farmaceutiskt preparat |
US4863737A (en) | 1985-05-01 | 1989-09-05 | University Of Utah | Compositions and methods of manufacture of compressed powder medicaments |
US4588580B2 (en) | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
IE60941B1 (en) | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
US4878892A (en) | 1987-02-10 | 1989-11-07 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
US4783450A (en) | 1987-04-13 | 1988-11-08 | Warner-Lambert Company | Use of commercial lecithin as skin penetration enhancer |
DK365389D0 (da) | 1989-07-24 | 1989-07-24 | Fertin Lab As | Antifungalt tyggegummipraeparat |
US5091186A (en) | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
TW279133B (da) | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
SE9101022D0 (sv) | 1991-01-09 | 1991-04-08 | Paal Svedman | Medicinsk suganordning |
US6746678B1 (en) | 1991-02-22 | 2004-06-08 | Howard K. Shapiro | Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments |
AU653026B2 (en) | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
ES2153362T3 (es) | 1991-08-26 | 2001-03-01 | Abbott Lab | Composiciones y procedimientos de administracion sublingual o bucal de agentes terapeuticos. |
NZ246091A (en) | 1991-12-24 | 1995-08-28 | Yamanouchi Pharma Co Ltd | Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol |
US5298256A (en) | 1992-04-28 | 1994-03-29 | Corint, Ltd. | Desmopressin buccal patch composition |
US5534496A (en) | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
US5343672A (en) | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
CA2090738C (en) | 1993-02-24 | 1996-05-21 | Hema-Quebec | Use of paf |
SE9300937L (sv) | 1993-03-19 | 1994-09-20 | Anne Fjellestad Paulsen | Komposition för oral administrering av peptider |
US5434121A (en) * | 1993-03-25 | 1995-07-18 | Mitsui Toatsu Chemicals, Incorporated | Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same |
SE501677C2 (sv) | 1993-06-18 | 1995-04-10 | Ferring Bv | Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel |
US5674850A (en) | 1993-12-23 | 1997-10-07 | Ferring Ab | High purity desmopressin produced in large single batches |
WO1995001368A1 (en) | 1993-06-29 | 1995-01-12 | Ferring B.V. | Improved synthesis of cyclic peptides |
HU221617B1 (hu) | 1993-06-29 | 2002-12-28 | Ferring B.V. | Vizes készítmény dezmopresszin nazális adagolására |
US5482931A (en) | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
US5500413A (en) | 1993-06-29 | 1996-03-19 | Ferring Ab | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
US5985835A (en) | 1993-12-23 | 1999-11-16 | Ferring B.V. | Desmopressin for nocturia, incontinence and enuresis |
CA2176927C (en) | 1993-11-17 | 2010-03-23 | Seang H. Yiv | Transparent liquid for encapsulated drug delivery |
SE9400918L (sv) | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
FR2720003B1 (fr) | 1994-05-23 | 1998-06-26 | Samsung Electro Mech | Dispositif servant à inciser la peau pour une médication transcutanée. |
DE4424800A1 (de) * | 1994-07-14 | 1996-01-18 | Philips Patentverwaltung | Schaltungsanordnung zum Liefern von Speisespannungen |
SE518619C2 (sv) | 1994-12-09 | 2002-10-29 | Gs Dev Ab | Komposition för reglerad frisättning innehållande monokaproin |
GB9502879D0 (en) | 1995-02-14 | 1995-04-05 | Oxford Biosciences Ltd | Particle delivery |
IL113459A (en) | 1995-04-23 | 2000-07-16 | Electromagnetic Bracing System | Electrophoretic cuff apparatus |
US5843016A (en) | 1996-03-18 | 1998-12-01 | Physion S.R.L. | Electromotive drug administration for treatment of acute urinary outflow obstruction |
TW411277B (en) | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
GB9612629D0 (en) | 1996-06-17 | 1996-08-21 | Oxford Biosciences Ltd | Method for providing dense particle compositions for use in transdermal particle delivery |
AU3399197A (en) | 1996-06-18 | 1998-01-07 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
US5763398A (en) | 1996-06-20 | 1998-06-09 | Ferring B.V. | Nasal administration of desmopressin |
US5922680A (en) | 1996-10-23 | 1999-07-13 | Ferring, B.V. | Stabilized composition for oral administration of peptides |
SE9604341D0 (sv) | 1996-11-26 | 1996-11-26 | Ferring Bv | Hepta-peptide oxytocin analogue |
FR2758195B1 (fr) | 1997-01-09 | 1999-02-26 | Sgs Thomson Microelectronics | Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele |
US5821230A (en) | 1997-04-11 | 1998-10-13 | Ferring Bv | GnRH antagonist decapeptides |
US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
US5932745A (en) | 1997-07-30 | 1999-08-03 | American Home Products Corporation | Process for converting propargylic amine-N-oxides to enaminones |
US6511974B1 (en) | 1997-07-30 | 2003-01-28 | Wyeth | Tricyclic vasopressin agonists |
US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
US7153845B2 (en) | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US20040018241A1 (en) | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
US6322532B1 (en) | 1998-06-24 | 2001-11-27 | 3M Innovative Properties Company | Sonophoresis method and apparatus |
US6090803A (en) | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
US7138393B2 (en) | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
US6148232A (en) | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
GB9827292D0 (en) | 1998-12-12 | 1999-02-03 | Univ Strathclyde | Freeze drying |
US6406455B1 (en) | 1998-12-18 | 2002-06-18 | Biovalve Technologies, Inc. | Injection devices |
US20060025387A1 (en) | 1998-12-23 | 2006-02-02 | Cytoscan Sciences Llc | Compositions and methods for the treatment of disorders of the central and peripheral nervous systems |
GB9901819D0 (en) | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
US6235900B1 (en) | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
US6620807B1 (en) | 1999-02-04 | 2003-09-16 | Wyeth | Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
US6344451B1 (en) | 1999-02-04 | 2002-02-05 | American Home Products | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
ATE283708T1 (de) | 1999-02-15 | 2004-12-15 | Sumitomo Pharma | Im mundraum schnellzerfallende tabletten |
US6314317B1 (en) | 1999-02-18 | 2001-11-06 | Biovalve Technologies, Inc. | Electroactive pore |
AR014640A1 (es) | 1999-02-23 | 2001-03-28 | Univ Nac Quilmes | UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE. |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US7060708B2 (en) | 1999-03-10 | 2006-06-13 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
US6210699B1 (en) | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
US6720001B2 (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
GB2355454A (en) | 1999-10-20 | 2001-04-25 | Ferring Bv | Antidiuretic agents |
US6558695B2 (en) | 1999-12-16 | 2003-05-06 | Dermatrends, Inc. | Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers |
GB0000079D0 (en) | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
WO2001051109A1 (en) | 2000-01-07 | 2001-07-19 | Biovalve Technologies, Inc. | Injection device |
US20070032410A1 (en) | 2000-01-11 | 2007-02-08 | Atossa Healthcare, Inc. | Compositions and methods for the treatment of psychiatric disorders |
AT409081B (de) | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
GB0015601D0 (en) | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
US6348486B1 (en) | 2000-10-17 | 2002-02-19 | American Home Products Corporation | Methods for modulating bladder function |
MXPA03003815A (es) | 2000-10-26 | 2004-08-12 | Johnson & Johnson | Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos. |
EP1339442A4 (en) | 2000-11-30 | 2006-12-27 | Biovalve Technologies Inc | INJECTION SYSTEMS |
CA2430590C (en) | 2000-11-30 | 2012-08-14 | Biovalve Technologies, Inc. | Fluid delivery and measurement systems and methods |
WO2002064193A2 (en) | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
WO2002050584A2 (en) | 2000-12-21 | 2002-06-27 | Biovalve Technologies, Inc. | Microneedle array systems |
CA2440884C (en) | 2001-03-16 | 2012-05-22 | Alza Corporation | Transdermal patch for administering fentanyl |
EP1381370B1 (en) | 2001-04-12 | 2007-03-07 | Wyeth | N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists |
CA2443870A1 (en) | 2001-04-12 | 2002-10-24 | Wyeth | Cyclohexylphenyl vasopressin agonists |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
GB2391480B (en) | 2002-08-05 | 2007-02-28 | Caretek Medical Ltd | Drug delivery system |
US7615234B2 (en) | 2001-09-11 | 2009-11-10 | Glide Pharmaceutical Technologies Limited | Drug delivery technology |
KR100874952B1 (ko) | 2001-09-13 | 2008-12-19 | 깃세이 야쿠힌 고교 가부시키가이샤 | 히드록시노르에페드린 유도체 염산염의 결정 |
US6723077B2 (en) | 2001-09-28 | 2004-04-20 | Hewlett-Packard Development Company, L.P. | Cutaneous administration system |
US6893655B2 (en) | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
KR100632882B1 (ko) | 2001-11-16 | 2006-10-13 | 아스텔라스세이야쿠 가부시키가이샤 | 4, 4-디플루오로-1, 2, 3,4-테트라하이드로-5h-1-벤즈아제핀 유도체 또는 그 염 |
WO2003094886A2 (en) | 2002-05-07 | 2003-11-20 | Ferring Bv | Desmopressin in an orodispersible dosage form |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
US6945952B2 (en) | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
CA2516547A1 (en) | 2002-09-30 | 2004-04-15 | Alza Corporation | Drug delivery device having coated microprojections incorporating vasoconstrictors |
JP4016986B2 (ja) | 2002-10-09 | 2007-12-05 | 東レ株式会社 | 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体 |
US7383084B2 (en) | 2002-10-31 | 2008-06-03 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized medications |
EP1428526A1 (en) | 2002-12-13 | 2004-06-16 | Rijksuniversiteit Groningen | Formulation for fast dissolution of lipophilic compounds |
DE10259934B3 (de) | 2002-12-20 | 2004-10-14 | H.C. Starck Gmbh | Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile |
AR042815A1 (es) | 2002-12-26 | 2005-07-06 | Alza Corp | Dispositivo de suministro de agente activo que tiene miembros compuestos |
SI1619185T1 (sl) | 2003-04-28 | 2011-09-30 | Astellas Pharma Inc | 4,4-difluoro-1,2,3,4-tetrahidro-5H-1-benzazepinski derivat ali njegova sol |
US20060193825A1 (en) | 2003-04-29 | 2006-08-31 | Praecis Phamaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
US7094545B2 (en) | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
DK1638468T3 (da) | 2003-06-30 | 2007-12-17 | Alza Corp | Fremgangsmåde til coating af hudpiercingmikrofremspring |
CN1826099B (zh) | 2003-07-25 | 2010-06-09 | 凡林有限公司 | 固体剂型药物组合物及其制造方法 |
US7022340B2 (en) | 2003-07-25 | 2006-04-04 | Ferring B.V. | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
US6930932B2 (en) | 2003-08-27 | 2005-08-16 | Hewlett-Packard Development Company, L.P. | Data signal reception latch control using clock aligned relative to strobe signal |
WO2005042054A2 (en) | 2003-10-24 | 2005-05-12 | Alza Corporation | Pretreatment method and system for enhancing transdermal drug delivery |
US20050089554A1 (en) | 2003-10-24 | 2005-04-28 | Cormier Michel J. | Apparatus and method for enhancing transdermal drug delivery |
EP1680154B1 (en) | 2003-10-31 | 2012-01-04 | ALZA Corporation | Self-actuating applicator for microprojection array |
EP2322195A2 (en) * | 2003-11-10 | 2011-05-18 | Reprise Biopharmaceutics, LLC | Pharmaceutical compositions including low dosages of desmopressin |
ES2260563T3 (es) | 2003-11-13 | 2006-11-01 | Ferring B.V. | Paquete de blister y forma farmaceutica solida para ello. |
SI1550439T1 (sl) | 2003-12-29 | 2006-08-31 | Ferring Bv | Postopek za pripravo trdne dozirne oblike dezmopresina |
US7018653B2 (en) | 2003-12-29 | 2006-03-28 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
CA2552754A1 (en) | 2004-01-09 | 2005-08-04 | Alza Corporation | Frequency assisted transdermal agent delivery method and system |
WO2006029411A2 (en) | 2004-09-09 | 2006-03-16 | Yeda Research And Development Co. Ltd. | Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof |
US7097776B2 (en) | 2004-10-22 | 2006-08-29 | Hewlett-Packard Development Company, L.P. | Method of fabricating microneedles |
US20060093658A1 (en) | 2004-10-26 | 2006-05-04 | Gayatri Sathyan | Apparatus and method for transdermal delivery of desmopressin |
CN100339081C (zh) | 2004-11-10 | 2007-09-26 | 范敏华 | 一种氯雷他定口腔崩解片剂的制备方法 |
US7180274B2 (en) | 2004-12-10 | 2007-02-20 | Aimtron Technology Corp. | Switching voltage regulator operating without a discontinuous mode |
BRPI0610046A2 (pt) | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de benzodioxano e benzodioxolano e usos destes |
US7856263B2 (en) | 2005-04-22 | 2010-12-21 | Travanti Pharma Inc. | Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis |
WO2006116151A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists |
MX2007012883A (es) | 2005-04-22 | 2007-12-10 | Wyeth Corp | Derivados de dihidrobenzofurano y usos de los mismos. |
CA2605587A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
CN101203216A (zh) | 2005-04-22 | 2008-06-18 | 惠氏公司 | 二氢苯并呋喃衍生物及其用途 |
CN101203217A (zh) | 2005-04-24 | 2008-06-18 | 惠氏公司 | 调节膀胱功能的方法 |
CA2612005C (en) | 2005-06-17 | 2013-10-29 | Georgia Tech Research Corporation | Coated microstructures and method of manufacture thereof |
WO2007002523A2 (en) | 2005-06-24 | 2007-01-04 | 3M Innovative Properties Company | Collapsible patch with microneedle array |
WO2007083323A2 (en) | 2006-01-23 | 2007-07-26 | Panacea Biotec Limited. | Modified release oral dosage form comprising desmopressin |
WO2007098945A2 (en) | 2006-03-02 | 2007-09-07 | Ferring International Center S.A. | Stable solid dosage form comprising desmopressin |
US8101114B2 (en) | 2006-05-01 | 2012-01-24 | Georgia Tech Research Corporation | Particle based molding |
RU2472539C2 (ru) | 2007-08-06 | 2013-01-20 | Аллерган, Инк. | Способы и устройства для доставки препарата десмопрессина |
PT3085381T (pt) * | 2008-05-21 | 2018-05-18 | Ferring Bv | Desmopressina orodispersível para aumentar o período inicial de sono não perturbado pela noctúria |
-
2009
- 2009-05-21 PT PT161658752T patent/PT3085381T/pt unknown
- 2009-05-21 SI SI200931838T patent/SI3085381T1/en unknown
- 2009-05-21 HU HUE13181216A patent/HUE030409T2/en unknown
- 2009-05-21 EP EP09751584.5A patent/EP2296686B2/en active Active
- 2009-05-21 EP EP16165875.2A patent/EP3085381B1/en active Active
- 2009-05-21 HU HUE17171155A patent/HUE046050T2/hu unknown
- 2009-05-21 NO NO09751584A patent/NO2296686T3/no unknown
- 2009-05-21 SI SI200932000T patent/SI3225250T1/sl unknown
- 2009-05-21 DK DK16165875.2T patent/DK3085381T3/da active
- 2009-05-21 PT PT171711559T patent/PT3225250T/pt unknown
- 2009-05-21 ES ES09751584.5T patent/ES2462465T5/es active Active
- 2009-05-21 JP JP2011510705A patent/JP5767103B2/ja active Active
- 2009-05-21 NO NO16165875A patent/NO3085381T3/no unknown
- 2009-05-21 SI SI200931494A patent/SI2712622T1/sl unknown
- 2009-05-21 US US12/469,801 patent/US9974826B2/en active Active
- 2009-05-21 PT PT97515845T patent/PT2296686E/pt unknown
- 2009-05-21 DK DK17171152.6T patent/DK3225249T3/da active
- 2009-05-21 TR TR2018/19189T patent/TR201819189T4/tr unknown
- 2009-05-21 PT PT131812166T patent/PT2712622T/pt unknown
- 2009-05-21 PL PL16165875T patent/PL3085381T3/pl unknown
- 2009-05-21 TR TR2018/07224T patent/TR201807224T4/tr unknown
- 2009-05-21 LT LT17171155T patent/LT3225250T/lt unknown
- 2009-05-21 PL PL09751584T patent/PL2296686T5/pl unknown
- 2009-05-21 ES ES16165875.2T patent/ES2677548T3/es active Active
- 2009-05-21 DK DK09751584.5T patent/DK2296686T4/da active
- 2009-05-21 ES ES13181216.6T patent/ES2596435T3/es active Active
- 2009-05-21 LT LTEP17171152.6T patent/LT3225249T/lt unknown
- 2009-05-21 ES ES17171152T patent/ES2710454T3/es active Active
- 2009-05-21 ES ES17171155T patent/ES2756706T3/es active Active
- 2009-05-21 HU HUE16165875A patent/HUE039013T4/hu unknown
- 2009-05-21 EP EP17171152.6A patent/EP3225249B1/en active Active
- 2009-05-21 PL PL17171155T patent/PL3225250T3/pl unknown
- 2009-05-21 EP EP13181216.6A patent/EP2712622B1/en active Active
- 2009-05-21 PL PL17171152T patent/PL3225249T3/pl unknown
- 2009-05-21 DK DK13181216.6T patent/DK2712622T3/da active
- 2009-05-21 CA CA2724653A patent/CA2724653A1/en not_active Abandoned
- 2009-05-21 SI SI200931912T patent/SI3225249T1/sl unknown
- 2009-05-21 PT PT17171152T patent/PT3225249T/pt unknown
- 2009-05-21 WO PCT/US2009/044860 patent/WO2009143356A1/en active Application Filing
- 2009-05-21 DK DK17171155T patent/DK3225250T3/da active
- 2009-05-21 HU HUE17171152A patent/HUE041370T2/hu unknown
- 2009-05-21 LT LTEP16165875.2T patent/LT3085381T/lt unknown
- 2009-05-21 PL PL13181216T patent/PL2712622T3/pl unknown
- 2009-05-21 LT LTEP13181216.6T patent/LT2712622T/lt unknown
- 2009-05-21 EP EP17171155.9A patent/EP3225250B1/en active Active
-
2015
- 2015-03-31 JP JP2015072698A patent/JP6001121B2/ja active Active
-
2016
- 2016-08-22 HR HRP20161066TT patent/HRP20161066T1/hr unknown
- 2016-08-31 JP JP2016169163A patent/JP6258424B2/ja active Active
-
2017
- 2017-01-20 LT LTPA2017001C patent/LTC2712622I2/lt unknown
- 2017-04-12 LU LU00015C patent/LUC00015I2/fr unknown
- 2017-12-06 JP JP2017234382A patent/JP6506821B2/ja active Active
-
2018
- 2018-01-26 US US15/880,697 patent/US20180250357A1/en not_active Abandoned
- 2018-05-17 HR HRP20180774TT patent/HRP20180774T1/hr unknown
-
2019
- 2019-01-18 HR HRP20190114TT patent/HRP20190114T1/hr unknown
- 2019-03-29 JP JP2019067813A patent/JP6836618B2/ja active Active
- 2019-04-26 HU HUS1900024C patent/HUS1900024I1/hu unknown
- 2019-04-30 NO NO2019021C patent/NO2019021I1/no unknown
- 2019-10-14 HR HRP20191854TT patent/HRP20191854T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180250357A1 (en) | Methods comprising desmopressin | |
US11020448B2 (en) | Methods comprising desmopressin | |
US11963995B2 (en) | Methods comprising desmopressin |